ChristopherRaymondGarrettMD

PubMed

• 1 citations
  Forgotten: mental health interventions in type 1 diabetes.
  Christopher R. Garrett, Khalida Ismail> ;Lancet. 2020 Jan 11
• 8 citations
  Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer.
  Amal Al Omari, Hadeel Abdelkhaleq, Maysa Al-Hussaini, Rim Turfa, Nour Awad, Manal M. Hassan, Mahmoud A. Alfaqih, Christopher R. Garrett> ;Journal of Global Oncology. 2018 Jun 12
• 36 citations
  Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response
  Xian De Liu, Goldy C. George, Apostolia-Maria Tsimberidou, Aung Naing, Jennifer J. Wheler, Scott Kopetz, Siqing Fu, Sarina Anne Piha-Paul, Cathy Eng, Gerald S. Falchoo...> ;BMC Cancer. 2015 Oct 16
• 87 citations
  Identification and characterization of RET fusions in advanced colorectal cancer.
  Anne-France Le Rolle, Samuel J. Klempner, Christopher R. Garrett, Tara Elisabeth Seery, Eric M. Sanford, Sohail Balasubramanian, Jeffrey S. Ross, Philip J. Stephens, V...> ;Oncotarget. 2015 Oct 6
• 12 citations
  Phase I study of everolimus, cetuximab and irinotecan as second-line therapy in metastatic colorectal cancer.
  J. Randolph Hecht, Tony R. Reid, Christopher R. Garrett, J. Thaddeus Beck, Sheldon J. Davidson, Mary J. MacKenzie, Ulrike Brandt, Syed Rizvi, Sunil Sharma> ;Anticancer Research. 2015 Mar 1
• 104 citations
  Antitumor Activity in RAS-Driven Tumors by Blocking AKT and MEK
  Anthony W. Tolcher, Khurum Khan, Michael Ong, Udai Banerji, Vassiliki A. Papadimitrakopoulou, David R. Gandara, Amita Patnaik, Richard D. Baird, David Olmos, Christoph...> ;Clinical Cancer Research. 2015 Feb 15
• 68 citations
  Association between KRAS mutation and lung metastasis in advanced colorectal cancer.
  Allan Andresson Lima Pereira, Juliana Florinda M. Rego, Van K. Morris, Michael J. Overman, Cathy Eng, Christopher R. Garrett, Adam T. Boutin, Renata Ferrarotto, Michae...> ;British Journal of Cancer. 2015 Feb 3
• 191 citations
  Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment
  Maria Pia Morelli, Michael J. Overman, Arvind Dasari, Syed Mohammad Ali Kazmi, Thibault Mazard, Eduardo Vilar, Van K. Morris, M. S. Lee, Delise H. Herron, Cathy Eng, J...> ;Annals of Oncology. 2015 Jan 26
• 93 citations
  Progression-free survival remains poor over sequential lines of systemic therapy in patients with BRAF-mutated colorectal cancer.
  Van K. Morris, Michael J. Overman, Zhi-Qin Jiang, Christopher R. Garrett, Shweta Agarwal, Cathy Eng, Bryan K. Kee, David R. Fogelman, Arvind Dasari, Robert A. Wolff, D...> ;Clinical Colorectal Cancer. 2014 Sep 1
• 19 citations
  Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer
  David R. Fogelman, Holly M. Holmes, Khalil Mohammed, Matthew H.G. Katz, Carla M. Prado, Jessica R L Lieffers, Naveen Garg, Gauri R. Varadhachary, Rachna T. Shroff, Mic...> ;Journal of Cachexia, Sarcopenia and Muscle. 2014 Apr 17
• 40 citations
  Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: Current state-of-the science
  Ibrahim Halil Sahin, Manal M. Hassan, Christopher R. Garrett> ;Cancer Letters. 2014 Apr 10
• 10 citations
  High prevalence of recurrent thrombosis in subsets of cancer patients with isolated gonadal vein thrombosis: a single center retrospective study.
  Suebpong Tanasanvimon, Naveen Garg, Chitra Viswanathan, Mylene T. Truong, Harmeet Kaur, Bryan K. Kee, Ibrahim Halil Sahin, Milind Javle, Christopher R. Garrett> ;Thrombosis Research. 2014 Feb 1
• 14 citations
  Preoperative Radiation Therapy With Concurrent Capecitabine, Bevacizumab, and Erlotinib for Rectal Cancer: A Phase 1 Trial
  Prajnan Das, Cathy Eng, Miguel A. Rodriguez-Bigas, George J. Chang, John M. Skibber, Y. Nancy You, Dipen M. Maru, Mark F. Munsell, Marilyn V. Clemons, Scott Kopetz, Ch...> ;International Journal of Radiation Oncology, Biology, Physics. 2014 Feb 1
• 86 citations
  A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC1 Compared With the Same Poxvectors Plus GM-CSF for Resec...
  Michael A. Morse, Donna Niedzwiecki, John L. Marshall, Christopher R. Garrett, David Z. Chang, Mebea Aklilu, Todd S. Crocenzi, David J. Cole, Sophie Dessureault, Amy H...> ;Annals of Surgery. 2013 Dec 1
• 34 citations
  Randomized phase 2 study of pegylated SN-38 (EZN-2208) or irinotecan plus cetuximab in patients with advanced colorectal cancer.
  Christopher R. Garrett, Tanios Bekaii-Saab, Theresa Ryan, George A. Fisher, Sally Clive, Petr Kavan, Einat Shacham-Shmueli, Aby Buchbinder, Richard M. Goldberg> ;Cancer. 2013 Dec 15
• 5 citations
  New drugs for gastrointestinal stromal tumors.
  Christopher R. Garrett> ;Clinical Advances in Hematology & Oncology. 2013 Oct 1
• 80 citations
  Metformin use and improved response to therapy in rectal cancer
  Heath D. Skinner, Christopher H. Crane, Christopher R. Garrett, Cathy Eng, George J. Chang, John M. Skibber, Miguel A. Rodriguez-Bigas, Patrick J. Kelly, Vlad C. Sandu...> ;Cancer Medicine. 2013 Feb 1
• Aspirin, PIK3CA mutation, and colorectal-cancer survival.
  Sahin IH, Garrett C> ;N. Engl. J. Med.. 2013-01-17
• 58 citations
  Rare Though Not Mutually Exclusive: A Report of Three Cases of Concomitant KRAS and BRAF Mutation and a Review of the Literature.
  Ibrahim Halil Sahin, Syed Mohammad Ali Kazmi, Jeffrey T. Yorio, Nishin A. Bhadkamkar, Bryan K. Kee, Christo pher R Garrett> ;Journal of Cancer. 2013 Jan 1
• 52 citations
  Adjuvant Chemotherapy With FOLFOX for Primary Colorectal Cancer Is Associated With Increased Somatic Gene Mutations and Inferior Survival in Patients Undergoing Hepate...
  Andreas Andreou, Scott Kopetz, Dipen M. Maru, Su S. Chen, Giuseppe Zimmitti, Antoine Brouquet, Junichi Shindoh, Steven A. Curley, Christopher R. Garrett, Michael J. Ov...> ;Annals of Surgery. 2012 Oct 1
• 18 citations
  Survival benefit associated with surgical oophorectomy in patients with colorectal cancer metastatic to the ovary.
  Christopher R. Garrett, Ben George, Chitra Viswanathan, Nishin A. Bhadkamkar, Sijin Wen, Veerarabhadran Baladandayuthapani, Y. Nancy You, Edmund S. Kopetz, Michael J. ...> ;Clinical Colorectal Cancer. 2012 Sep 1
• 65 citations
  Prospective randomised evaluation of traditional Chinese medicine combined with chemotherapy: a randomised phase II study of wild toad extract plus gemcitabine in pati...
  Zhiqiang Meng, Christopher R. Garrett, Yehua Shen, L. Liu, P. Yang, Y. Huo, Qi Zhao, A R Spelman, C. S. Ng, David Z. Chang, L Cohen> ;British Journal of Cancer. 2012 Jul 24
• 91 citations
  Complete Longitudinal Analyses of the Randomized, Placebo-Controlled, Phase III Trial of Sunitinib in Patients with Gastrointestinal Stromal Tumor following Imatinib F...
  George D. Demetri, Christopher R. Garrett, Patrick Schöffski, Manisha H. Shah, Jaap Verweij, Serge Leyvraz, Herbert Hurwitz, Antonio López Pousa, Axel Le Cesne, David ...> ;Clinical Cancer Research. 2012 Jun 1
• 3 citations
  A Primer on the Current State-of-the-Science Neoadjuvant and Adjuvant Therapy for Patients with Locally Advanced Rectal Adenocarcinomas.
  Jeffrey T. Yorio, Nishin A. Bhadkamkar, Bryan K. Kee, Christopher R. Garrett> ;International Journal of Surgical Oncology. 2012 May 16
• 118 citations
  Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
  Christopher R. Garrett, Hesham M. Hassabo, Nishin A. Bhadkamkar, Sijin Wen, Veerabhadran Baladandayuthapani, Bryan K. Kee, Cathy Eng, Manal M. Hassan> ;British Journal of Cancer. 2012 Apr 10
• Join now to see all